Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2026
Efficacy and Safety of Nanoencapsulated Sirolimus plus Pegadricase: Results from the Randomized, Placebo-Controlled Phase 3 TrialsHerbert S B Baraf, Puja P Khanna, Milan Petronijevic, et al.
Annals of Internal Medicine|August 19, 2009
Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trialRaphaela Goldbach-Mansky, Mildred Wilson, Roy Fleischmann, et al.
Annals of the Rheumatic Diseases|July 4, 2025
Highly selective tyrosine kinase 2 inhibition with zasocitinib (TAK-279) improves outcomes in patients with active psoriatic arthritis: a randomised phase 2b studyAlan Kivitz, Xenofon Baraliakos, Elena Tomaselli Muensterman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2021
Reducing Immunogenicity of Pegloticase With Concomitant Use of Mycophenolate Mofetil in Patients With Refractory Gout: A Phase II, Randomized, Double-Blind, Placebo-Controlled TrialPuja P Khanna, Dinesh Khanna, Gary Cutter, et al.
Modern Rheumatology|April 2, 2022
Integrated safety analysis of filgotinib treatment for rheumatoid arthritis in patients from Japan over a median of 1.5 yearsNaoki Ishiguro, Yoshiya Tanaka, Tsukasa Matsubara, et al.
Annals of Internal Medicine|September 27, 2021
The Safety and Immunologic Effectiveness of the Live Varicella-Zoster Vaccine in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy : A Randomized Controlled TrialJeffrey R Curtis, Stacey S Cofield, S Louis Bridges, et al.
Lupus Science & Medicine|October 12, 2017
Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritisMichael J Boedigheimer, David A Martin, Zahir Amoura, et al.
Annals of the Rheumatic Diseases|January 28, 2021
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trialBernard Combe, Alan Kivitz, Yoshiya Tanaka, et al.
Rheumatology (Oxford, England)|October 20, 2019
A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritisCynthia Aranow, John Cush, Marcy B Bolster, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 2015
A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trialBente L Langdahl, Christence Stubbe Teglbjærg, Pei-Ran Ho, et al.
Pageof 10